Ibandronate
Supplier:
Catalogue number:
10-4630-01
Size:
50 mg
Product is available in:
Farnesyl pyrophosphate synthase inhibitor/ osteoporosis drug / Ibandronate is a clinically useful drug for the prevention and treatment of osteoporosis and skeletal fractures in patients with cancer. It is a potent inhibitor of farnesyl pyrophosphate synthase (IC50 = 20 nM) and strongly binds to hydroxyapatite.1
Product Type:
Biochemicals & reagents
CAS Number:
138926-19-9
Alternative Names:
BM-21.0955
Reference:
1) Russell (2006), Ibandronate: Pharmacology and preclinical studies; Bone 38 S7
Storage Temperature:
-20°C
Additional Information:
PATHWAY: Posttranslational modification -- DISEASE AREA: Osteoporosis